NCT00217737 2026-03-18
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
12 trialsNCT01918527 2026-03-10
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
Vejle Hospital
Phase 3 Active not recruiting
NCT01460589 2026-02-12
ECTX
Kyungpook National University Hospital
Phase 3 Active not recruiting
NCT03426904 2026-02-11
Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer
Kyungpook National University Hospital
Phase 3 Active not recruiting
NCT02912559 2026-02-02
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT03428477 2025-04-18
EMT2
University of Leeds
Phase 3 Active not recruiting
NCT02572141 2025-03-19
OPTICAL
Sun Yat-sen University
Phase 3 Active not recruiting
NCT04793958 2025-02-11
KRYSTAL-10
Mirati Therapeutics Inc.
Phase 3 Active not recruiting
NCT06709144 2024-11-29
BLARCC
Zhejiang Cancer Hospital
Phase 3 Active not recruiting
NCT03464305 2024-03-19
ASPIRIN
University Hospital, Antwerp
Phase 3 Active not recruiting
NCT02301286 2024-03-18
ASPIRIN
Leiden University Medical Center
Phase 3 Active not recruiting